Skip to main content
. 2022 Sep 23;13(10):1678–1684. doi: 10.1021/acsmedchemlett.2c00216

Figure 4.

Figure 4

Location of the trihalo-sulfone 1 in WNK1/1. (A) The inhibitor binds in the active site to a complementary site. Drawn in PyMol. (B) Schematic of the site indicating the pockets defined by Gray22 and residues involved in inhibitor hydrogen bonding.